Udenyca 6 MG/0.6 ML syringe 0.6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3NU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,098
Award facts
- Contract value 100% obligated
- $58,097.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,097.87 firm fixed-price delivery order to Amerisourcebergen Drug Corp for 6 mg/0.6 mL Udenyca syringes. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of January 21, 2026. Amerisourcebergen, operating through its corporate office in Conshohocken, Pennsylvania, will serve as the prime contractor for this pharmaceutical delivery. This award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp is a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor that specializes in supplying prescription medications, medical devices, and healthcare commodities to federal agencies. The Udenyca order supports DLA's medical supply chain objectives by procuring a critical injectable medication commonly used in cancer treatment protocols. As a competitively awarded non-set-aside contract, this delivery order demonstrates Amerisourcebergen's established capability to meet federal procurement requirements and maintain its role as a key pharmaceutical vendor within the military healthcare system's supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FG3NU?
SPE2DR26FG3NU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FG3NU worth?
The government has obligated $58,098 on SPE2DR26FG3NU.
Is contract SPE2DR26FG3NU an order under another contract?
Yes. SPE2DR26FG3NU is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3NU competed?
The extent of competition for SPE2DR26FG3NU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award